These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 6968353)
21. E rosette test in infectious mononucleosis. Bergiel A; Zieliński A Allergol Immunopathol (Madr); 1979; 7(6):417-22. PubMed ID: 317218 [No Abstract] [Full Text] [Related]
22. Lymphocytotoxins in infectious mononucleosis: a non-cytotoxic effect on lymphocytes at 37 degrees C and the influence of cell metabolism on their cytotoxicity in vitro. Quin JW; Charlesworth JA; Yasmeen D; Macdonald GJ; Pussell BA Clin Exp Immunol; 1981 Feb; 43(2):285-90. PubMed ID: 7273482 [TBL] [Abstract][Full Text] [Related]
23. [Analysis using monoclonal antibodies of subpopulations of T-lymphocytes in infectious mononucleosis]. Jordá Tormo J; Alvarez-Sala Walther JL; Arias Pérez JI; Alvarez Carmona A; Espinós Pérez D Med Clin (Barc); 1982 Sep 1-15; 79(4):181-4. PubMed ID: 6216377 [No Abstract] [Full Text] [Related]
24. Biologic and molecular characterization of the IgG serum blocking factor (SBF-IgG) isolated from sera of patients with EBV-induced infectious mononucleosis. Veltri RW; Kikta VA; Wainwright WH; Sprinkle PM J Immunol; 1981 Jul; 127(1):320-8. PubMed ID: 6263976 [TBL] [Abstract][Full Text] [Related]
25. A novel T cell activation antigen identified by monoclonal IMN3.1 antibody and expressed preferentially on human T cells susceptible to apoptotic cell death. Uehara T; Miyawaki T; Natsuume-Sakai S; Nibu R; Hasui M; Yachie A; Shimizu S; Taniguchi N J Immunol; 1993 Apr; 150(8 Pt 1):3243-53. PubMed ID: 7682236 [TBL] [Abstract][Full Text] [Related]
26. Effect of hydrazide cysteine on T cells. II. Human autologous rosette forming cells belong to two subpopulations differing with respect to the sensitivity to hydrocortisone and hydrazide cysteine. Zimecki M; Zwoliński J; Ryzewski J; Wieczorek Z Arch Immunol Ther Exp (Warsz); 1984; 32(3):281-5. PubMed ID: 6335390 [TBL] [Abstract][Full Text] [Related]
27. Monoclonal anti-human T-lymphocyte antibodies: enumeration and characterization of T-cell subsets. Van Wauwe J; Goossens J Immunology; 1981 Jan; 42(1):157-64. PubMed ID: 6970173 [TBL] [Abstract][Full Text] [Related]
28. Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1. White CA; Cross SM; Kurilla MG; Kerr BM; Schmidt C; Misko IS; Khanna R; Moss DJ Virology; 1996 May; 219(2):489-92. PubMed ID: 8638417 [TBL] [Abstract][Full Text] [Related]
29. Infectious mononucleosis: increase of high-affinity E-receptor-bearing lymphocytes. Naess A; Talstad I; Solberg CO Int Arch Allergy Appl Immunol; 1987; 83(2):178-81. PubMed ID: 3495495 [TBL] [Abstract][Full Text] [Related]
30. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection. Ohga S; Nomura A; Takada H; Tanaka T; Furuno K; Takahata Y; Kinukawa N; Fukushima N; Imai S; Hara T J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517 [TBL] [Abstract][Full Text] [Related]
31. Morphologic observations of contact-induced lysis of EBV-infected B lymphocytes by autologous hand mirror T cells. Thomas WJ; Duval-Arnould B; Creegan WJ; Schumacher HR; Forman DS; Strong DM Am J Hematol; 1982 Apr; 12(2):109-19. PubMed ID: 6280495 [TBL] [Abstract][Full Text] [Related]
32. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection. Wingate PJ; McAulay KA; Anthony IC; Crawford DH J Med Virol; 2009 May; 81(5):870-7. PubMed ID: 19319950 [TBL] [Abstract][Full Text] [Related]
33. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection. Sugaya N; Kimura H; Hara S; Hoshino Y; Kojima S; Morishima T; Tsurumi T; Kuzushima K J Infect Dis; 2004 Sep; 190(5):985-8. PubMed ID: 15295706 [TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease. Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978 [TBL] [Abstract][Full Text] [Related]
35. Glucocorticoid receptor content of T lymphocytes: evidence for heterogeneity. Distelhorst CW; Benutto BM J Immunol; 1981 Apr; 126(4):1630-4. PubMed ID: 6970782 [TBL] [Abstract][Full Text] [Related]
36. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load. Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A; J Infect Dis; 2006 Mar; 193(5):664-71. PubMed ID: 16453261 [TBL] [Abstract][Full Text] [Related]
37. High Th1-type cytokine serum levels in patients with infectious mononucleosis. Corsi MM; Ruscica M; Passoni D; Scarmozzino MG; Gulletta E Acta Virol; 2004; 48(4):263-6. PubMed ID: 15745050 [TBL] [Abstract][Full Text] [Related]
38. Influence of fetal calf serum on the results of the E rosette test. Naess A Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):77-9. PubMed ID: 6869018 [TBL] [Abstract][Full Text] [Related]
39. Antibodies to human T lymphocytes in xenoantisera elicited with a new immature T-cell line (Peer). Schlesinger M; Rabinowitz R; Kertes T; Ravid Z; Goldblum N Thymus; 1981 Feb; 2(4-5):235-43. PubMed ID: 7015584 [TBL] [Abstract][Full Text] [Related]
40. T cell cytokine profile during primary Epstein-Barr virus infection (infectious mononucleosis). Attarbaschi T; Willheim M; Ramharter M; Hofmann A; Wahl K; Winkler H; Graninger W; Winkler S Eur Cytokine Netw; 2003; 14(1):34-9. PubMed ID: 12799212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]